Issue 1/2008
Content (10 Articles)
Open Access
Recombinant Human Epo Treatment: Beneficial in Chronic Kidney Disease, Chronic Heart Failure, or Both?
A. M. S. Belonje, R. A. de Boer, A. A. Voors
Effects of Hawthorn on Cardiac Remodeling and Left Ventricular Dysfunction after 1 Month of Pressure Overload-induced Cardiac Hypertrophy in Rats
Hyun Seok Hwang, Barry E. Bleske, Michael M. J. Ghannam, Kimber Converso, Mark W. Russell, James C. Hunter, Marvin O. Boluyt
Trimetazidine Protective Effect Against Ischemia-Induced Susceptibility to Ventricular Fibrillation in Pigs
Fanny Vaillant, Panayota Tsibiribi, Giampiero Bricca, Bernard Bui-Xuan, Anne Bescond-Jacquet, Alain Tabib, Jacques Descotes, Quadiri Timour
Correction of Anemia with Erythropoietin in Chronic Kidney Disease (stage 3 or 4): Effects on Cardiac Performance
Konstantinos D. Pappas, Chariklia D. Gouva, Konstantinos P. Katopodis, Petros M. Nikolopoulos, Panagiotis G. Korantzopoulos, Lampros K. Michalis, John A. Goudevenos, Kostas C. Siamopoulos
A Meta-Analysis of Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in the Treatment of Acute Myocardial Infarction
Lin Fan, Lianglong Chen, Xiangqi Chen, Fayuan Fu
Lipoprotein Associated Phospholipase A2 Inhibition Reduces Generation of Oxidized Fatty Acids
Robert S. Rosenson, Marina Vracar-Grabar, Irene Helenowski
Use of Anticoagulants in ST-Segment Elevation Myocardial Infarction Patients; A Focus on Low-Molecular-Weight Heparin
Hitinder S. Gurm, Kim A. Eagle